leuprolide and Memory-Disorders

leuprolide has been researched along with Memory-Disorders* in 3 studies

Trials

2 trial(s) available for leuprolide and Memory-Disorders

ArticleYear
Memory complaints associated with the use of gonadotropin-releasing hormone agonists: a preliminary study.
    Fertility and sterility, 1996, Volume: 65, Issue:6

    To study the effect of GnRH agonist (GnRH-a) treatment on memory and to assess the role of psychological factors.. A randomized prospective study.. An academic teaching hospital.. Women with endometriosis and infertility or endometriosis alone.. Memory Observation Questionnaire, Profile of Mood States, Health Concerns scale, a weekly diary of adverse effects.. Perceived memory functioning decreased during GnRH-a administration and by the final week of treatment 44% of women reported moderate to marked impairment in comparison to community norms. Prospective memory was most affected and withdrawal of GnRH-a treatment resulted in a return to normal memory functioning. Impairment was not related to excessive health concerns or mood changes and was uncorrelated with other adverse effects.. Memory disruption may be a more common side effect of GnRH-a treatment than currently is recognized. Problems were temporary and more likely a result of rapid estrogen depletion than a consequence of mood, somatic distress, or personality factors.

    Topics: Adult; Endometriosis; Estradiol; Female; Humans; Leuprolide; Memory Disorders; Nafarelin; Prospective Studies

1996
"Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri.
    The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:7

    Treatment of women with uterine myomas with GnRH agonists results in symptoms of hypoestrogenism which can be prevented by concurrent "add-back" estrogen administration. We took advantage of these induced endocrine changes to investigate their effects on cognitive functioning in young women with myomas. Nineteen women with uterine myomas were tested before treatment. They all received the GnRH agonist, leuprolide acetate depot (LAD), every 4 weeks for 12 weeks and were then randomized to receive LAD plus estrogen or LAD plus placebo every 4 weeks for 8 additional weeks. Levels of all sex hormones decreased after 12 weeks of LAD treatment (P < 0.01), and only estradiol (E2) levels increased (P < 0.01) following 8 weeks of subsequent treatment in the group that received LAD plus E2. Scores on neuropsychological tests of verbal memory decreased from pretreatment to 12 weeks posttreatment with LAD (P < 0.05). These memory deficits were reversed in the group that received LAD plus E2 for 8 weeks coincident with an increase in plasma E2, whereas memory scores remained depressed in the group that received LAD plus placebo. These findings are consistent with those from studies on surgically menopausal women and strongly suggest that estrogen serves to maintain verbal memory in women. These results provide support for the efficacy of add-back estrogen regimens in women treated with GnRH agonists and also imply that estrogen may be important for maintaining memory in the postmenopause.

    Topics: Adult; Cognition Disorders; Delayed-Action Preparations; Estradiol; Female; Humans; Leiomyoma; Leuprolide; Memory Disorders; Uterine Neoplasms

1996

Other Studies

1 other study(ies) available for leuprolide and Memory-Disorders

ArticleYear
Neuropsychologic dysfunction in women following leuprolide acetate induction of hypoestrogenism.
    Journal of assisted reproduction and genetics, 1993, Volume: 10, Issue:1

    The study investigated the neuropsychological status of women with induced hypoestrogenism.. An ABA design was employed in which neuropsychological measures were repeated prior to, during, and after induction of hypoestrogenism with leuprolide acetate.. The study took place in a medical school affiliated in vitro fertilization clinic.. Leuprolide acetate was administered to all subjects as part of in vitro fertilization.. Eighteen women receiving in vitro fertilization treatment underwent neuropsychological testing before, during, and after treatment with leuprolide acetate and gonadotrophins. The neuropsychological test battery was selected on the basis of previous patients' symptomatic complaints during periods of hypoestrogenism with leuprolide acetate.. Depending upon the tests administered, some individuals showed significant cognitive deficits during therapy particularly in the areas of memory, fine motor coordination, and two-point discrimination. Two of the 18 subjects showed very substantial neuropsychological sequelae including memory gaps and disturbances in a variety of neuropsychological test performances. However, in terms of group statistics, only two-point discrimination and delayed recall memory test performance proved significant. Not all measures were sensitive for the group, as many tests displayed a balance between individuals who showed practice effects and those who showed detrimental effects.. For a substantial portion of individuals, hypoestrogenism can result in statistically significant or clinically noteworthy problems with memory, dexterity, and two-point discrimination.

    Topics: Adult; Cognition Disorders; Estrogens; Female; Fertilization in Vitro; Humans; Leuprolide; Memory Disorders; Motor Activity; Neuropsychological Tests

1993